What about Ganjiang New Area Laiwei Regenerative Medicine Technology Co., Ltd.?

According to the data, Ganjiang New Area Laiwei Regenerative Medicine Technology Co., Ltd. was established on March 4, 2020 with a registered capital of 50 million RMB and 9 participants. It is an enterprise mainly engaged in research and experimental development. The company has been awarded the qualification and honor of "national science and technology small and medium-sized enterprises", which has a certain scale and strength.

In terms of intellectual property rights, Ganjiang New Area Laiwei Regenerative Medicine Technology Co., Ltd. has 2 registered trademarks and 8 patent information. In addition, Ganjiang New Area Laiwei Regenerative Medicine Technology Co., Ltd. also invested in 1 enterprise and directly controlled 1 enterprise.

If you want to know more about Ganjiang New Area Laiwei Regenerative Medicine Technology Co., Ltd., go to the enterprise to learn about it-check the enterprise, check the boss, check the risks for free and find business opportunities.